Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

145.13
+11.818.86%
Post-market: 145.840.7114+0.49%19:59 EDT
Volume:87.32M
Turnover:12.92B
Market Cap:57.94B
PE:-18.12
High:159.47
Open:133.11
Low:132.42
Close:133.32
52wk High:176.66
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:1.40
T/O Rate:23.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:8.57
PE(LYR):-19.99

Loading ...

Sector Update: Healthcare

MT Newswires Live
·
Aug 19

William Blair Upgrades Moderna to Outperform From Market Perform

MT Newswires Live
·
Aug 19

US Stocks-Wall St Set for Higher Open After Retail Earnings; Moderna Soars

Reuters
·
Aug 19

Moderna extends rally, shares up 89% to $118.99 after melonoma data

TIPRANKS
·
Aug 19

Moderna upgraded to Outperform from Market Perform at William Blair

TIPRANKS
·
Aug 19

Biotech Stocks Jump Premarket After Moderna's Melanoma Vaccine with Merck Succeeds in Large Trial

THOMSON REUTERS
·
Aug 19

The Bond Selloff is Rattling Investors, but Here's Why They Shouldn't Expect a Deeper Stock Downturn

Dow Jones
·
Aug 19

The "Holy Grail" Of Cancer Treatment? Moderna's Melanoma MRNA Vaccine Succeeds In Phase 3 Trial

Options & Short Sell
·
Aug 19

Moderna Shares More than Double Premarket; Last up 103%

THOMSON REUTERS
·
Aug 19

Stocks to Watch: Oracle, SK Hynix, Moderna, Unitree

Dow Jones
·
Aug 19

US Stocks-Wall St Futures Flat After Tech Rout; Iran Tensions, Retail Earnings in Focus

Reuters
·
Aug 19

Moderna, Merck, La-Z-Boy, SK Hynix, and More Stocks That Explain Today's Market

Dow Jones
·
Aug 19

U.S. Stocks on the MOVE-Estee Lauder, Target, Analog Devices

Reuters
·
Aug 19

Merck, Moderna Say Potential Melanoma Therapy Shows 'Statistically Significant Improvement' in Late-Stage Trial

MT Newswires Live
·
Aug 19

Bond Yields, Persian Gulf Outlooks Cap Wall Street Pre-Bell; Asia, Europe Off

MT Newswires Live
·
Aug 19

Moderna Stock Surges 70%, Merck Rises 6%. at Last, a Successful Cancer Vaccine.

Dow Jones
·
Aug 19

Moderna and Merck Say Melanoma Skin Cancer Vaccine Meets Goals in Large Trial

Reuters
·
Aug 19

Moderna Vaccine Cuts Recurrence and Spread of High-Risk Melanoma, Raising New Treatment Hope

Reuters
·
Aug 19

Moderna jumps 54% to $97.52 after Phase 3 INTerpath-001 trial met endpoints

TIPRANKS
·
Aug 19

Moderna Shares Extend Gains; Last up 46.9% Premarket

THOMSON REUTERS
·
Aug 19